Fortress Biotech Announces Virtual Two-Day Corporate Access Summit Hosted by B. Riley FBR on Tuesday, August 18 and Wednesday, August 19, 2020

NEXT STORY
Daré Bioscience Reports Second Quarter 2020 Financial Results and Provides Company Update
PREV STORY
Ascendis Pharma A/S Receives Orphan Designation for TransCon™ CNP for the Treatment of Achondroplasia in Europe
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Enhanced MuScreen™ Platform Revolutionizes Preclinical Development of Immunotherapeutics

SAN DIEGO, Feb. 09, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, a wholly-owned subsidiary of ...

author_avatar
NASDAQ Market News

Aptevo Therapeutics Reports Second Quarter 2019 Financial Results

author_avatar
NASDAQ Market News

Global Point of Care Diagnostics/Testing Market 2019-2025 – Growing Demand for Home Healthcare and the Introduction of Advance Technology Enabled Products

author_avatar
NASDAQ Market News